GlaxoSmithKline PLC

(LSE, Stocks) 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

p 1,499.50 <%= Resources.Global.txtUp %>
Updated 12:01:33
ISIN: GB0009252882
Change % 0.20% Stock price increasing
Change 3.00 Stock price increasing
Volume 1,931,744
High P 1,500.68
Low P 1,486.50
Open P 1,488.50
Prev close P 1,496.50
# of shares -
Market cap -

GlaxoSmithKline PLC
Market is open (until 16:30) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  1,499.50 0.7% Stock price increasing 7.3% Stock price increasing 7.2% Stock price increasing 5.7% Stock price increasing -4.9% Stock price decreasing

Company profile

GlaxoSmithKline (GSK) is a global pharmaceutical company with the majority of sales coming from pharmaceuticals followed by consumer healthcare. Most of the growth for GSK is coming from consumer healthcare because of declining pharmaceutical sales and margins from mature markets. The sector is highly dependent on expensive, long term R&D to develop new drugs. To establish a stronger brand presence in China and India, the company has aggressively cut prices to increase volumes in these markets.

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
29 January 2015 12:16:48
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150128.1 - EUROWEB7 - 2015-01-29 13:16:48 - 2015-01-29 12:16:48 - 1000 - Website: OKAY